Nephrology Dialysis Transplantation, Vol 14, Issue 5 1085-1090, Copyright © 1999 by Oxford University Press
U Frei, H Schober-Halstenberg and Q Task Group for Quality Assurance in Renal Replacement Therapy
During the past 3 years, the basis of a German Renal Registry has been
established. An agreement between end-stage renal disease (ESRD) therapy
providers, insurance companies and the government has been reached to fund
and support the registry office and its electronic data base. An overall
acceptable compliance has been achieved to provide data voluntarily,
although in the future the data submission will have to be mandatory to
achieve complete data sampling within an acceptable time frame. In Germany,
713 patients per million population (p.m.p.) are on renal replacement
therapy (RRT). The incidence of new patients commencing RRT is 156 p.m.p.
These numbers are comparable with those reported from other European
countries such as France, Italy and Spain, but significantly lower than
those reported from other European countries such as France, Italy and
Spain, but significantly lower than those reported from the US or Japan.
More than 92% of all dialysis patients are treated by haemodialysis and
only a limited number with peritoneal dialysis. Approximately 25% of the
patients have a functioning kidney graft. The transplantation rate of 25
p.m.p. is far from sufficient if compared with Spain, Austria or the US.
Although an increasing number of diabetic patients commenced RRT, the
percentage, i.e. ∼30%, is less than in the US or Japan. The annual
growth of the population on renal replacement cannot currently be given
precisely because the database is still limited, but it seems to be
∼3-4%.
DIALYSIS AND TRANSPLANTATION NEWS
Annual report of the German renal registry 1998
Department of Nephrology and Medical Intensive Care, Universitatsklinikum Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, D-13353 Berlin, Germany; Projektgeschaftsstelle QuaSi-Niere, Berlin, Germany; Corresponding author
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. F.E. Mann, R. E. Schmieder, L. Dyal, M. J. McQueen, H. Schumacher, J. Pogue, X. Wang, J. L. Probstfield, A. Avezum, E. Cardona-Munoz, et al. Effect of Telmisartan on Renal Outcomes: A Randomized Trial Ann Intern Med, July 7, 2009; 151(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schiel, S. Heinrich, T. Steiner, U. Ott, and G. Stein Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus Nephrol. Dial. Transplant., March 1, 2005; 20(3): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stengel, S. Billon, P. C.W. van Dijk, K. J. Jager, F. W. Dekker, K. Simpson, and J. D. Briggs Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999 Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1824 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jungers, G. Choukroun, C. Robino, Z. A. Massy, P. Taupin, M. Labrunie, N.-K. Man, and P. Landais Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998 Nephrol. Dial. Transplant., December 1, 2000; 15(12): 2000 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rutkowski Changing pattern of end-stage renal disease in central and eastern Europe Nephrol. Dial. Transplant., February 1, 2000; 15(2): 156 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Amenabar, F. Garcia-Lopez, N. R. Robles, R. Saracho, M. Calero, M. A. Gentil, M. J. Aladren, E. Martin-Martinez, J. Bestard, J. Marco, et al. 1997 Spanish Nephrology Association (Sociedad Espanola de Nefrologia) Report on Dialysis and Transplantation Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2841 - 2845. [Full Text] [PDF]
|
|